Author

Mitchell Edwards

VenatoRx Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Allison L. Zulli· 1 shared Ann E. JerseiD· 1 shared Annie StevensoniD· 1 shared Anthony S. Drager· 1 shared Bei WangiD· 1 shared Brittany Miller· 1 shared Caleb M. StrattoniD· 1 shared Cassandra L. Chatwin· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Allison L. Zulli

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae

Tsuyoshi Uehara, Allison L. Zulli, Brittany Miller, Lindsay M. Avery, Steven A. Boyd, Cassandra L. Chatwin, Guo‐Hua Chu, Anthony S. Drager, Mitchell Edwards, Susan G. Emeigh Hart, Nathan J. Line, Cullen L. Myers, Gopinath Rongala, Annie Stevenson, Kyoko Uehara, , Stephen M. Condon

This paper identifies a novel benzoxaborinine-based inhibitor (VNRX-14079) that effectively targets penA-mediated resistance in multidrug-resistant Neisseria gonorrhoeae.

Nature Microbiology · Apr 8, 2026Peer-reviewedMicrobiology